Intelligent Bio Solutions Statistics Share Statistics Intelligent Bio Solutions has 7.43M
shares outstanding. The number of shares has increased by 62.6%
in one year.
Shares Outstanding 7.43M Shares Change (YoY) 62.6% Shares Change (QoQ) 1.87% Owned by Institutions (%) 15.2% Shares Floating 7.34M Failed to Deliver (FTD) Shares 608 FTD / Avg. Volume 0.33%
Short Selling Information The latest short interest is 576.83K, so 6.42% of the outstanding
shares have been sold short.
Short Interest 576.83K Short % of Shares Out 6.42% Short % of Float 6.49% Short Ratio (days to cover) 4.35
Valuation Ratios The PE ratio is -0.86 and the forward
PE ratio is 4.43.
Intelligent Bio Solutions's PEG ratio is
0.01.
PE Ratio -0.86 Forward PE 4.43 PS Ratio 2.97 Forward PS 0.5 PB Ratio 3.03 P/FCF Ratio -0.92 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Intelligent Bio Solutions.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.77,
with a Debt / Equity ratio of 0.09.
Current Ratio 0.77 Quick Ratio 0.65 Debt / Equity 0.09 Debt / EBITDA -0.03 Debt / FCF -0.03 Interest Coverage -174.82
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $61.05K Profits Per Employee $-211.37K Employee Count 50 Asset Turnover 0.37 Inventory Turnover 2.84
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -7.82% in the
last 52 weeks. The beta is 4.59, so Intelligent Bio Solutions's
price volatility has been higher than the market average.
Beta 4.59 52-Week Price Change -7.82% 50-Day Moving Average 1.66 200-Day Moving Average 1.63 Relative Strength Index (RSI) 55.71 Average Volume (20 Days) 182,859
Income Statement In the last 12 months, Intelligent Bio Solutions had revenue of 3.05M
and earned -10.57M
in profits. Earnings per share was -2.
Revenue 3.05M Gross Profit 1.25M Operating Income -10.64M Net Income -10.57M EBITDA -9.34M EBIT -10.54M Earnings Per Share (EPS) -2
Full Income Statement Balance Sheet The company has 1.02M in cash and 281.81K in
debt, giving a net cash position of 738.1K.
Cash & Cash Equivalents 1.02M Total Debt 281.81K Net Cash 738.1K Retained Earnings -62.53M Total Assets 8.25M Working Capital -1.21M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -9.68M
and capital expenditures -231.84K, giving a free cash flow of -9.91M.
Operating Cash Flow -9.68M Capital Expenditures -231.84K Free Cash Flow -9.91M FCF Per Share -1.88
Full Cash Flow Statement Margins Gross margin is 40.85%, with operating and profit margins of -348.71% and -346.23%.
Gross Margin 40.85% Operating Margin -348.71% Pretax Margin -346.23% Profit Margin -346.23% EBITDA Margin -305.85% EBIT Margin -348.71% FCF Margin -324.62%
Dividends & Yields INBS does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for INBS.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 29, 2024. It was a
backward
split with a ratio of 1:12.
Last Split Date Jan 29, 2024 Split Type backward Split Ratio 1:12
Scores Altman Z-Score -13.34 Piotroski F-Score 2
